Effect of a Modified Oxygen Mask Associated to Nasal Prongs During a High Flow Oxygenation Method
Oxygen Inhalation Therapy
About this trial
This is an interventional treatment trial for Oxygen Inhalation Therapy focused on measuring oxygen mask, high-flow oxygen therapy, acute respiratory failure
Eligibility Criteria
Inclusion Criteria:
Regardless of gender, at least 18 years of age and diagnosed with severe Hypoxia (PaO2/FiO2 < 300 mm Hg), dyspnea with severe rest at stake accessory muscles of respiration, respiratory rate (RR) ≥ 25 CPM, PaCO2 ≤ 45 mmHg, patient with an arterial catheter and without hemodynamic instability, Glasgow Coma Scale ≥ 12/15, written consent. Participants were also required to have a sufficient level of education to understand study procedures and be able to communicate with site personnel.
Exclusion Criteria Patients were excluded if they Hypercapnia (> 45 mm Hg with respiratory acidosis), cardiogenic pulmonary edema, COPD, pulmonary fibrosis, hypoventilation obesity syndrom, arterial pressure < 60 mm Hg or treatment by epinephrine > to 0,1 gamma/kg/minute, deterioration of awareness (Glasgow scale < or = 12), acute confusional state.
Participants were randomized in a 1:1 ratio to receive either (CHFONP) classical High Flow Oxygenation with nasal prongs (20 minutes) or CHFNOP with an adjunctive of a DTM.
-
Sites / Locations
- epicura Hornu
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Oxygenation only with nasal canula
Oxygenation with double trunk masknasal canula
intervention: classical oxygenation with nasal canula (High flow)
oxygenationwith DTM above nasal canula